Healionics

edit

Healionics began with a biomedical breakthrough. After years of dedicated research, Dr. Buddy Ratner and Dr. Andrew Marshall of the University of Washington Engineered Biomaterials group (UWEB), discovered the “sweet spot” - the precise pore size and geometry that allows biomaterial to promote the acceptance of biomedical devices within the body.

Milestones

edit

• 
  Healionics received $2.6M in Series B funding. (12/11/08)
  Posted 6/15/09 at 11:08pm
• 
  Healionics added Max Maginness as Chief Technology Officer.
  Posted 6/15/09 at 11:14pm
• 
  Healionics added Michel Alvarez as Chief Executive Officer.
  Posted 6/15/09 at 11:14pm
• 
  Healionics added Andrew Marshall as Principal Scientist.
  Posted 6/15/09 at 11:14pm

Videos

Screenshots

edit

Above: Healionics
Uploaded: 6/16/09

Sources

1. Healionics Corporation Raises $2.6 Million from Angels (biospace.com) [edit]